semaglutide ocular side effects linked to higher risk of vision problems, FDA data analysis shows Wegovy Vision Loss Lawsuit [2026

Among individuals with obesity and type 2 diabetes, both medications were associated with lower hazards of anxiety disorders, broadly defined cognitive deficits, mood disorders, and depression

However, intentionally pushing to day 10 or 12 risks noticeable appetite rebound and reduced weight loss velocity

It is FDA-approved for both type 2 diabetes management (GLP-1 also known as Ozempic) and chronic weight management (GLP-1 also known as Wegovy) in individuals with obesity or overweight conditions

Is the carnivore diet healthy or just a meaty myth

Pharmacological treatment typically begins with non-insulin antihyperglycemic agents, either as monotherapy or in combination

Efficacy and safety of GLP-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized clinical trials